-
. However, progress is constrained by the scarcity of high-quality, well-characterized in vitro T-cell immunogenicity data. In this project, we will leverage expertise and technology in peptide T-cell
-
, measuring, basic brain science, etc.), Medical Science (brain medical science, immunology, oncology, genome science, etc.) and Engineering that relate to research being conducted at RIKEN. Qualifications
-
AI in the context of the Human Cell Atlas and the European Lab for Learning & Intelligent Systems. Wet-lab: Tissue immunology, immunotherapy, cell engineering, and/or synthetic biology (Bock Lab ). We
-
have developed a range of genetic engineering strategies to modify EVs for the purpose of drug delivery. In addition to EVs, the EL Andaloussi lab also engineers various conjugates for extrahepatic